Prompted by a finding that the angiotensin-receptor blocker losartan prevented cardiovascular events more effectively than atenolol in hypertensive patients with left ventricular hypertrophy ...

Patients receiving atenolol tended to have a lower risk of stroke than patients on placebo; one study showed a 43% reduction in stroke risk, but most patients in that study were treated with more ...

As for blood pressure reduction, the target of <140/90 mm Hg was achieved in only 49% of the losartan patients and 46% of the atenolol patients. Finally, the study group was diverse in inclusion ...